SCX (scleraxis) is a bHLH transcription factor that functions as a DNA-binding transcriptional regulator with critical roles in musculoskeletal development and tissue regeneration. Mechanistically, SCX acts as an RNA polymerase II-specific transcriptional activator that binds E-box elements to regulate gene expression during developmental processes 1. SCX marks distinct progenitor populations essential for tendon and ligament development; embryonic tendon-to-bone attachments develop from unique Sox9- and Scx-positive cells that are distinct from mature tenocytes and chondrocytes 2. In mature tendons, SCX identifies a specialized quiescent Scx+/Axin2+ population that serves as a major functional contributor to tendon healing and repair, expressing stem cell markers with multilineage differentiation potential 3. Following tendon injury, Scx-lineage tenocytes show increased proliferation and migration regulated by PI3K-Akt signaling, which promotes stemness and inhibits mature differentiation during neonatal tendon regeneration 4. Clinically, SCX-marked cells represent a promising therapeutic target for enhancing tendon repair, particularly given that pediatric tendons heal more efficiently than adult tendons with minimal scarring 4. The ability to identify and potentially expand Scx+ progenitor populations could inform regenerative medicine approaches for treating tendon injuries, which currently carry high recurrence rates 2.